Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.

Klaassen, R J

Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis. [electronic resource] - Transplantation Sep 1997 - 780-2 p. digital

Publication Type: Journal Article

0041-1337

10.1097/00007890-199709150-00023 doi


Angiotensin Receptor Antagonists
Biphenyl Compounds--pharmacology
Erythrocyte Count--drug effects
Hematocrit
Humans
Imidazoles--pharmacology
Kidney Transplantation--adverse effects
Losartan
Platelet Aggregation Inhibitors--pharmacology
Polycythemia--blood
Tetrazoles--pharmacology